newsfilter
← Latest News
FDA Approved Drugs·

Approval of Scemblix, Nda #215358 (Labeling)

Approval Date: 09/22/2026; Drug Name: Scemblix, Nda #215358; Active Ingredients: ASCIMINIB HYDROCHLORIDE; Company: Novartis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 215358

Company
NOVARTIS
Keywords
NOVARTIS